Understanding Food and Drug Administration Regulatory Requirements for an Investigational Device Exemption for Sponsor-Investigators

Abstract

Clinical investigators in academic medical centers often perceive federal regulations as a significant obstacle to conducting clinical research. The regulatory authority of the Food and Drug Administration (FDA) extends to clinical studies of medical devices. Consequently, researchers wishing to conduct device research using FDA-approved as well as nonapproved devices must comply with federal regulations for investigational device exemptions (IDE) as described in Title 21 of the Code of Federal Regulations Part 812. FDA regulatory oversight is structured to match the risk to the subject to the risk of the device. Medical device studies can be categorized as follows: meeting exemption criteria, being a nonsignificant risk device, or being a significant risk device. All IDE studies must meet regulations for the protection of human subjects, but no additional federal filing on the part of the investigator is necessary for those that meet exempt criteria. Nonsignificant risk device studies require meeting abbreviated IDE regulatory requirements for the conduct of the study, but no previous FDA approval is required. Significant risk device studies require that the investigator also function as a sponsor and to file an IDE with the FDA for approval before starting. A sponsor-investigator filing an IDE follows the format and content described in 21 CFR 812.20. The study may begin 30 days after the date of submission receipt unless the FDA notifies the sponsor otherwise. While the IDE is active, the sponsor-investigator must meet the requirements for the conduct of the study and the required monitoring and reporting to the FDA.

Keywords

Food and Drug Administration investigational device exemption federal regulations significant risk device

Get full access to this article

View all access options for this article.

References

Protection of Human Subjects . Title 45 C.F.R. Part 46. (2011).

Medical Devices . Title 21 C.F.R. Part 812 Subchapter H (2011).

Federal Food, Drug, and Cosmetic Act, 21 U.S.C. (2010 Edition).

Federal Food, Drug, and Cosmetic Act, 21 U.S.C. Subchapter II–Definitions. (2010 Edition).

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors: Frequently Asked Questions About Medical Devices. 2006. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM127067.pdf. Accessed May 30, 2012.

Device Classification. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/default.htm. Accessed May 30, 2012.

General and Special Controls. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/GeneralandSpecialControls/default.htm. Accessed May 30, 2012.

Design Control Guidance For Medical Device Manufacturers. Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm070627.htm. Accessed May 30, 2012.

Device Classification Panels. 2011. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051530.htm. Accessed May 30, 2012.

10.

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors: Significant Risk and Nonsignificant Risk Medical Device Studies. 2006. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126418.pdf. Accessed May 30, 2012.

11.

IDE Definitions and Acronyms. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm046698.htm. Accessed May 30, 2012.

12.

Berro

, Burnett

, Fromell

. Support for investigator-initiated clinical research involving investigational drugs or devices: the Clinical and Translational Science Award experience. Acad Med. 2011; 86 (2): 217–223.

13.

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors. 2006. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM127067.pdf. Accessed May 29, 2012.

14.

Device Advice: Comprehensive Regulatory Advice. 2012. Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/default.htm. Accessed May 30, 2012.

15.

Procedures for Handling Inquiries Regarding the Need for an Investigational Device Exemptions Application for Research Involving Medical Devices. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm126598.htm. Accessed May 30, 2012.

16.

IDE Application. 2011 Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm046706.htm. Accessed May 30, 2012.

17.

Spurgin

EA.

Planning for effective interaction with FDA. Diabetes Technol Ther. 2004; 6 (6): 770–775.

18.

CDRH Premarket Review Submission Cover Sheet. Available at: http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM080872.pdf. Accessed May 29, 2012.

19.

Good Laboratory Practice For Nonclinical Laboratory Studies. Title 21 C.F.R. Part 58.

20.

IDE Financial Disclosure. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm051337.htm. Accessed May 30, 2012.

21.

FDA. Guidance on IDE Policies and Procedures. 2009 Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080202.htm. Accessed May 30, 2012.

22.

About the Center for Devices and Radiological Health. Available at: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/default.htm. Accessed May 30, 2012.

23.

US Public Law 110-85 (Food and Drug Administraiton Amendments Act of 2007), Title VIII, Section 801.

24.

DeAngelis

, Drazen

, Frizelle

. Clinical trial registration. JAMA. 2004; 292: 1363–1364.

25.

IDE Reports. 2009. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm046717.htm. Accessed May 30, 2012.

26.

FDA. Changes or Modifications During the Conduct of a Clinical Investigation; Final Guidance for Industry and CDRH Staff. 2011 Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm082145.htm. Accessed May 30, 2012.

27.

Guidance for Industry Oversight of Clinical Investigators: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM269919.pdf. Accessed May 30, 2012.

28.

FAQs about IDE. 2011. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm051480.htm. Accessed May 30, 2012.